Georgemorstyn
cardiology
Board Director
Forbes and Dunagan
Japan
Biography
Former Senior Vice-President of Development and CMO, Amgen Inc. Dr. Morstyn, an outstanding scholar in oncogenetics, was a pioneer in the clinical trial development of hematopoietic growth factors. During his tenure at Amgen, five drug products received marketing approval by US FDA and were subsequently launched. After returning to Australia, he was appointed to the Board of Directors of Bionomics Limited, Glykoz Pty Limited, and the Royal Women's Hospital in Melbourne. He is Currently chief executive officer of G & R Morstyn Pty Ltd., and serves on the Director of several Australian companies, including, Chairman GBS Venture Capital firm, Deputy Chairman Victorian Comprehensive Cancer Centre, Director of Co-operative Research Centre for Cancer Therapeutics and Therapeutic Innovation Australia. In 2013 has been elected a fellow of ATSE (The Australian Academy of Technological Sciences and Engineering).
Research Interest
pharmaceutical industry.
